Supplementary Figure 2 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells

Abstract
Transient siRNA Knockdown of IL1R1 reduces erlotinib-induced IL-6 secretion.